3 Essentials For A Fit-For-Purpose Compliance Strategy In Decentralized Pharma

April 1, 2022
By Penelope Przekop
Compliance
Quality
Quality Assurance
Consultants

We discuss three essentials for designing a compliance strategy to ensure patient safety and data integrity throughout the decentralized drug development process.

About the Author

Penelope Przekop, CEO

MSQA, RQAP-GCP

Penelope Przekop is a is a biopharmaceutical quality assurance and corporate compliance executive consultant with global R&D and commercial PV expertise. During the early 2000s, she developed and oversaw the first global PV quality and compliance departments established for Wyeth as well as Johson & Johnson. Her work includes qualification and oversight of numerous PV vendors covering all aspects of clinical safety and post-marketed PV. Penelope has facilitated numerous PV regulatory inspections. She frequently leads and conducts PV mock inspections and provides in-depth PV training.

Related Content

Read more from PDC’s teams of experts.

A 3-Point Strategy For Training Part-Time GCP Consultants

Global biopharma regulations and guidelines require that individuals involved in conducting clinical trials be qualified by a combination of education, training, and experience. The components are straightforward to implement regarding internal employees, but not so clear when it comes to part-time consultants contracted to intermittently execute specific good clinical practice (GCP) tasks. Discover three trips for training independent consultants.

Learn more
A 3-Point Strategy For Training Part-Time GCP Consultants

Global biopharma regulations and guidelines require that individuals involved in conducting clinical trials be qualified by a combination of education, training, and experience. The components are straightforward to implement regarding internal employees, but not so clear when it comes to part-time consultants contracted to intermittently execute specific good clinical practice (GCP) tasks. Discover three trips for training independent consultants.

Learn more
4 Imperatives For Updating Our Clinical Quality Systems Approach For 2022 Pharma

The clinical quality management systems approach developed 20 years ago is not sustainable in the today's industry because we've seen dramatic industry changes in outsourcing, remote monitoring, the use of electronic systems in clinical research, and more. But how do we update our approach for 2022 pharma? This article examines 4 imperatives, including how to accomplish them.

Learn more
4 Imperatives For Updating Our Clinical Quality Systems Approach For 2022 Pharma

The clinical quality management systems approach developed 20 years ago is not sustainable in the today's industry because we've seen dramatic industry changes in outsourcing, remote monitoring, the use of electronic systems in clinical research, and more. But how do we update our approach for 2022 pharma? This article examines 4 imperatives, including how to accomplish them.

Learn more
The Growing Value of Quality & Compliance Professionals in Decentralized Pharma

Find out the reasons why our industry, your company, and employees should value the unique skillset of the quality and compliance professionals more than ever in decentralized pharma.

Learn more
The Growing Value of Quality & Compliance Professionals in Decentralized Pharma

Find out the reasons why our industry, your company, and employees should value the unique skillset of the quality and compliance professionals more than ever in decentralized pharma.

Learn more
PDC Pharma Strategy is the #1 pharmaceutical consulting firm in 2024

Qualio recognizes PDC Pharma Strategy as the top 1 pharmaceutical consulting firm one should consider for 2024.

Learn more
PDC Pharma Strategy is the #1 pharmaceutical consulting firm in 2024

Qualio recognizes PDC Pharma Strategy as the top 1 pharmaceutical consulting firm one should consider for 2024.

Learn more

How can we help you?

Reach out to schedule a consultation.

Contact PDC